- Center on Health Equity & Access
- Clinical
- Health Care Cost
- Health Care Delivery
- Insurance
- Policy
- Technology
- Value-Based Care
Dr Robert Pendleton Focuses on Patients During the Transition to Value-Based Payments
The current environment is a difficult time for hospitals and health systems that are trying to do well while also starting to transition to a value-based payment system, explained Robert Pendleton, MD, chief medical quality officer for University of Utah Healthcare.
The current environment is a difficult time for hospitals and health systems that are trying to do well while also starting to transition to a value-based payment system, explained Robert Pendleton, MD, chief medical quality officer for University of Utah Healthcare in Salt Lake City, Utah.
Despite the difficulty of making the transition, what tends to rally people is if they focus on the real reason why change is necessary.
“It’s not about our national healthcare crisis, it’s really about doing better for our patients, developing a delivery system that is more effective and efficient for our patients,” Dr Pendleton said.
Impact of Amivantamab-Lazertinib on EGFR, MET Resistance Alterations in NSCLC: Danny Nguyen, MD
September 15th 2025The combination of amivantamab and lazertinib in first-line non–small cell lung cancer (NSCLC) significantly reduces resistance mechanisms with implications for second-line treatment, said Danny Nguyen, MD, of City of Hope.
Read More
Disparities in Biomarker Testing Impact Nonsquamous NSCLC Outcomes: Surbhi Singhal, MD
September 6th 2025Surbhi Singhal, MD, of the University of California Davis, discussed disparities in biomarker testing among patients diagnosed with stage IV nonsquamous non–small cell lung cancer (NSCLC).
Read More
